RECIL versus Lugano for Treatment Response Assessment in FDG-Avid Non-Hodgkin Lymphomas: A Head-to-Head Comparison in 54 Patients.

导出 OA

翻译打印收藏纠错

作者： Dominik,Berzaczy ^[1] ; Alexander,Haug ^[2] ; Philipp B,Staber ^[3] ; Markus,Raderer ^[4] ; Barbara,Kiesewetter ^[4] ; Ulrich,Jaeger ^[3] ; Christoph,Kornauth ^[5] ; Ingrid,Simonitsch-Klupp ^[5] ; Marius E,Mayerhoefer ^[1]

作者单位： Department of Biomedical Imaging and Image-guided Therapy, Division of General and Pediatric Radiology, Medical University of Vienna, 1090 Vienna, Austria. ^[1] Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, 1090 Vienna, Austria. ^[2] Department of Medicine I, Division of Hematology, Medical University of Vienna, 1090 Vienna, Austria. ^[3] Department of Medicine I, Division of Oncology, Medical University of Vienna, 1090 Vienna, Austria. ^[4] Institute of Pathology, Medical University of Vienna, 1090 Vienna, Austria. ^[5] Department of Radiology, Memorial Sloan-Kettering Cancer Center, 10065 NY, USA. ^[6]

关键词 FDG PET/CT lymphoma treatment response

DOI 10.3390/cancers12010009

PMID 31861433

发布时间 2020-09-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览5

Cancers

2019年12卷1期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

RECIL versus Lugano for Treatment Response Assessment in FDG-Avid Non-Hodgkin Lymphomas: A Head-to-Head Comparison in 54 Patients.

Cancers

相似文献

Cancers

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

RECIL versus Lugano for Treatment Response Assessment in FDG-Avid Non-Hodgkin Lymphomas: A Head-to-Head Comparison in 54 Patients.

Cancers

相似文献

Cancers

相关期刊

检索历史清除